1 study found for:    "NJMS" OR "New Jersey Medical School" | Open Studies | "Intestinal Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Biological: bevacizumab;   Drug: XELOX regimen;   Drug: hydroxychloroquine

Indicates status has not been verified in more than two years